» Articles » PMID: 36986591

New Frontiers in Three-Dimensional Culture Platforms to Improve Diabetes Research

Overview
Journal Pharmaceutics
Publisher MDPI
Date 2023 Mar 29
PMID 36986591
Authors
Affiliations
Soon will be listed here.
Abstract

Diabetes mellitus is associated with defects in islet β-cell functioning and consequent hyperglycemia resulting in multi-organ damage. Physiologically relevant models that mimic human diabetic progression are urgently needed to identify new drug targets. Three-dimensional (3D) cell-culture systems are gaining a considerable interest in diabetic disease modelling and are being utilized as platforms for diabetic drug discovery and pancreatic tissue engineering. Three-dimensional models offer a marked advantage in obtaining physiologically relevant information and improve drug selectivity over conventional 2D (two-dimensional) cultures and rodent models. Indeed, recent evidence persuasively supports the adoption of appropriate 3D cell technology in β-cell cultivation. This review article provides a considerably updated view of the benefits of employing 3D models in the experimental workflow compared to conventional animal and 2D models. We compile the latest innovations in this field and discuss the various strategies used to generate 3D culture models in diabetic research. We also critically review the advantages and the limitations of each 3D technology, with particular attention to the maintenance of β-cell morphology, functionality, and intercellular crosstalk. Furthermore, we emphasize the scope of improvement needed in the 3D culture systems employed in diabetes research and the promises they hold as excellent research platforms in managing diabetes.

Citing Articles

Application of 3D printing in the treatment of diabetic foot ulcers: current status and new insights.

Li X, Ai X, Wang B, Luo M, Miyamoto A, Kuchay M Front Bioeng Biotechnol. 2024; 12:1475885.

PMID: 39605746 PMC: 11598536. DOI: 10.3389/fbioe.2024.1475885.


Cell identity dynamics and insight into insulin secretagogues when employing stem cell-derived islets for disease modeling.

Wang C, Abadpour S, Aizenshtadt A, Dalmao-Fernandez A, Hoyem M, Wilhelmsen I Front Bioeng Biotechnol. 2024; 12:1392575.

PMID: 38933536 PMC: 11199790. DOI: 10.3389/fbioe.2024.1392575.


Advances in the application of extracellular vesicles derived from three-dimensional culture of stem cells.

Chen W, Wu P, Jin C, Chen Y, Li C, Qian H J Nanobiotechnology. 2024; 22(1):215.

PMID: 38693585 PMC: 11064407. DOI: 10.1186/s12951-024-02455-y.


Advancements in culture technology of adipose-derived stromal/stem cells: implications for diabetes and its complications.

Shi Y, Yang X, Min J, Kong W, Hu X, Zhang J Front Endocrinol (Lausanne). 2024; 15:1343255.

PMID: 38681772 PMC: 11045945. DOI: 10.3389/fendo.2024.1343255.

References
1.
Gurlin R, Giraldo J, Latres E . 3D Bioprinting and Translation of Beta Cell Replacement Therapies for Type 1 Diabetes. Tissue Eng Part B Rev. 2020; 27(3):238-252. DOI: 10.1089/ten.TEB.2020.0192. View

2.
Dhuria R, Singh G, Kaur A, Kaur R, Kaur T . Current status and patent prospective of animal models in diabetic research. Adv Biomed Res. 2015; 4:117. PMC: 4513317. DOI: 10.4103/2277-9175.157847. View

3.
Bi S, Moran T . Obesity in the Otsuka Long Evans Tokushima Fatty Rat: Mechanisms and Discoveries. Front Nutr. 2016; 3:21. PMC: 4961687. DOI: 10.3389/fnut.2016.00021. View

4.
Chan B, Leong K . Scaffolding in tissue engineering: general approaches and tissue-specific considerations. Eur Spine J. 2008; 17 Suppl 4:467-79. PMC: 2587658. DOI: 10.1007/s00586-008-0745-3. View

5.
Samuelson L, Gerber D . Improved function and growth of pancreatic cells in a three-dimensional bioreactor environment. Tissue Eng Part C Methods. 2012; 19(1):39-47. DOI: 10.1089/ten.TEC.2012.0236. View